Nanotechnology intellectual property in Brazil: Preliminary research note

Chamas, Claudia

doi:10.1016/j.wpi.2007.11.001

Cited by 9 publications

(5 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For a NT inventor, it is a risk of inventing a technology that may infringe another patent, or a technology that cannot be patented. In the 1980s and 1990s, such the phenomenon was observed in the biotechnology sector (Chamas, 2008). In general, NT and biotechnology have very comparable development patterns.…”

Section: Brief Insights Into Nt Patentingmentioning

confidence: 82%

See 1 more Smart Citation

Systemic insights into nanotechnology patenting in EU countries

Jemala¹

2015

IJASM

View full text Add to dashboard Cite

Although modern nanotechnology (NT) is a new discipline, nano-scale materials were used for centuries, for example, gold and silver particles have created colours in the stained glass windows of churches since the ancient time. Today, there is not a unified definition of what precisely NT is, because NT has an interdisciplinary nature. A growing interest in NT, a growing number of NT innovation and patents raise the question, what makes NT so attractive? This paper has two main goals and parts. The methodological section provides a clear insight into the development, main issues of patenting, searching and categorisation of NT. This part is often overlooked in many scientific papers on NT, which brings many inaccuracies for this discipline. The analytical section provides a clear insight into nanotechnology patenting in Europe, based on the comprehensive EPO patent database analysis .

show abstract

Section: Brief Insights Into Nt Patentingmentioning

confidence: 82%

“…The practice of the USPTO, JPO, EPO, WIPO was adopted by the most of the countries (Chamas, 2008). Patent cooperation treaty (1970) facilitates to file a patent application in many countries at the same time.…”

Section: Brief Insights Into Nt Patentingmentioning

confidence: 99%

Systemic insights into nanotechnology patenting in EU countries

Jemala¹

2015

IJASM

View full text Add to dashboard Cite

show abstract

“…Due to serious environmental and health risk posed by the release of nanoparticles in the environment, it becomes essential to set specific standards for the manufacture, use, and disposal of nanoparticles (Choi, et al, 2009). There are many fail reports about legislations do not mention or define nanoparticles (Chamas, 2008). However, a number of organizations have evolved development, description and usage-associated standards for nanoparticles.…”

Section: Discussionmentioning

confidence: 99%

Patents, Drug Delivery and Public Health Protection: Health Risk Management for Nanopharmaceuticals

Sant'Anna

Ferreira²,

Alencar³

2013

Journal of Technology Management & Innovation

View full text Add to dashboard Cite

The present article discusses the general risks associated with nanotechnology applications and the defcits of the risk management of engineered nanopharmaceutical particles. An evaluation of the possible health or environmental risks of nanoparticles must systematically be carried out and it is important to ensure that particle size and chemistry are taken into account when investigating possible adverse effects. It has been a goal subsidizes the policy-makers to adapt and modernize the regulatory framework on nanotechnology and risks involving health as a strategic area in the politics of Science. It is essential that health and environment be always directly or indirectly involved in various researches to understand the causes of affections and to develop control procedures in order to avoid them, providing results achievable, reliable and secure

show abstract

“…Pre výskumníka v oblasti NT existuje značné riziko, že vynájde technológiu, ktorá môže porušiť iné patentové práva, alebo ktorú nemožno patentovať. V rokoch 1980-1990 bol tento jav charakteristický pre odvetvie biotechnológií (Chamas, 2008). Všeobecne platí, že odvetvie NT a biotechnológií majú veľmi porovnateľné vzorce vlastného rozvoja.…”

unclassified

“…Táto schéma by mala zlepšiť účinnosť a kvalitu Európskeho patentového systému prostredníctvom užšej spolupráce národných patentových úradov EÚ a EPO (IPO.GOV, 2013). Rôznorodosť NT však volá po jednotnom rámci na ochranu práv DV spojeného s NT (Chamas, 2008). Aj keď prax najznámejších patentových úradov ako sú USPTO, JPO, EPO, alebo WIPO prijala väčšina krajín vrátane SR a ČR.…”

unclassified

Selected Systemic Conclusions of Patent Analysis on Nanotechnology in the Eu-28

Jemala¹,

Jemala²

2015

AAK

View full text Add to dashboard Cite

Certain fundamentals of the nanotechnology (NT) discipline can be already found in 1870, when two professors Elihu Thomson and Edwin Houston experimented and later patented inventions on the existing arc lamps and dynamo design. The emergence of NT as a new scientific discipline can be found a hundred years later and it is also connected with the invention of the scanning tunneling microscope and the discovery of fullerenes. Among the first companies that patented NT were: General Electric, Unisys, Honeywell, DuPont, Bell Labs, and IBM. Among the first patenting areas of NT were: nano-materials, nano-manufacturing and nano-interactions. This scientific study has two particular goals. Methodological part (Chapter 1 and 2) provides a clear insight into selected topical issues of patenting, searching and categorization of NT. This part is often overlooked/simplified in many scientific papers on NT, which brings a lot of uncertainty for this discipline. The second part is the systemic analysis (Chapter 3) that is to provide a clear insight into the patented NT in the EU, based on the comprehensive statistics of the European database of EPO patents (1940-2015). But, the main scientific goal of this study is to make some conclusions for the promotion of innovation and patenting NT in the EU.

show abstract

Nanotechnology intellectual property in Brazil: Preliminary research note

Cited by 9 publications

References 9 publications

Systemic insights into nanotechnology patenting in EU countries

Systemic insights into nanotechnology patenting in EU countries

Patents, Drug Delivery and Public Health Protection: Health Risk Management for Nanopharmaceuticals

Selected Systemic Conclusions of Patent Analysis on Nanotechnology in the Eu-28

Contact Info

Product

Resources

About